Diastolic DysfunctionNeonatal EncephalopathySmall for Gestational Age at DeliveryTransient Tachypnea of the NewbornTrisomy 21Gestational Diabetes
Study summary
The goal of this single-centre longitudinal observational study is to create reference values for diastolic function parameters in neonates born at 35 weeks' gestation or above, and to assess the influence of pre-defined antenatal, intrapartum, maternal, and neonatal factors on cardiac function.
The main question it aims to answer are:
* What are the normal reference ranges for parameters of diastolic cardiac function in neonates?
* How are these influenced by maternal, intrapartum and neonatal factors?
* Do the diastolic changes noted during the first two days of life persist into infancy?
Participants will have four echocardiographic assessments in total:
* Two during the first 48 hours of life (prior to discharge home)
* Two during infancy (as an outpatient)
Eligibility
Sex
ALL
Min age
6 Hours
Max age
18 Hours
Healthy volunteers
Accepted
Inclusion Criteria:
* Birth at 35 weeks gestation or above
* Informed consent obtained
Exclusion Criteria:
* Any apparent congenital anomalies
* Any known chromosomal abnormalities (except Trisomy 21)
* Any known congenital structural heart disease (except patent ductus arteriosus, atrial septal defect, patent foramen ovale or ventricular septal defect)
Primary outcome measure(s)
Reference values for diastolic function parameters in neonates — Day 1 and Day 2 of life Establish reference values for conventional and novel echocardiographic methods of assessing diastolic function in neonates and stratify them by different antenatal, intrapartum, maternal and neonatal factors to assess whether there is an association between these factors and cardiac function.
Persistence of diastolic function changes into infancy — 6 - 9 months of life, 12 - 18 months of life Assess whether the diastolic function changes noted in the first few days persist over time.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.